Prehabilitation interventions have shown encouraging results for those undergoing physically and psychologically demanding treatments for their cancer. Prehabilitation for cancer surgery research has increased rapidly in recent years. Numerous studies have investigated effects in people living with the gastrointestinal (GI) cancer, but less so in the hepatopancreatobiliary (HPB) cancer patient group. That said, recommendations for practice and implementation are difficult due to heterogeneity of interventions. This presentation will summarise the recent evolving evidence for prehabilitation in GI and HPB cancers, drawing on key studies that highlight its impact on patient recovery. We will also share insights from our local experience delivering prehabilitation at Flinders Medical Centre. This will include recent research investigating perspectives with a focus on barriers and facilitators to engagement in a public setting. These findings highlight the importance of patient preferences, flexible delivery models, and clear consistent communication in supporting uptake. Ultimately, this talk aims to provide an update on prehabilitation in these cohorts and offer practical insights and strategies for integration into routine cancer care.